Overexpression of Inducible Nitric Oxide Synthase by Neointimal Smooth Muscle Cells
Abstract—The formation of a neointima represents an important repair mechanism in response to vascular injury. It is associated with the expression of a specific set of genes by the intimal smooth muscle cells. Recently, expression of the inducible isoform of NO synthase (iNOS) has been identified in injured arteries during neointimal formation, suggesting that intimal SMCs have a unique mechanism for regulating NO production. Therefore, we have analyzed the expression of iNOS in intimal SMCs. Although first expressed in the media within 1 day after injury, iNOS was confined to neointimal smooth muscle cells at 1 to 2 weeks after injury. Isolated intimal SMCs were found to consistently reexpress iNOS in reaction to proinflammatory mediators. This was associated with a 5- to 8-fold higher output of NO in comparison with SMCs derived from the media of uninjured arteries. Western blot and Northern blot analyses likewise revealed that the high production of NO by intimal SMCs was due to overexpression of iNOS. Moreover, the same stimuli induced a higher transcriptional activity in intimal than in medial SMCs, as detected by transfection of a reporter gene under the iNOS promoter. Induction of iNOS led to a reduced proliferation in both medial and intimal SMCs. This inhibitory effect was, however, less pronounced in intimal than in medial SMCs. Similarly, intimal cells were less sensitive to NO-induced inhibition of mitochondrial respiration. When SMC clones were analyzed, there was no correlation between iNOS expression and growth pattern, suggesting that iNOS expression is independent of the morphological phenotype of SMCs. Together, our data show that the intimal SMC is the main iNOS-expressing cell type in the injured artery, that it responds more vividly to iNOS-inducing cytokines because of a more efficient activation of the iNOS promoter, and that it is more resistant to the actions of NO compared with medial SMCs. Intimal production of NO via the inducible pathway may be important for the restoration of vascular homeostasis after injury.
- nitric oxide
- nitric oxide synthase (EC 18.104.22.168)
- vascular smooth muscle cell
- transcriptional regulation
Vascular smooth muscle cells form a neointima as a response to tissue injury. For instance, removal of the arterial endothelium and intima by a balloon catheter results in SMC migration from media to surface and, subsequently, an intense phase of cell proliferation and matrix synthesis in the developing neointima.1 2 3 4 5 Although the molecular mechanisms responsible for the formation of the neointima are far from elucidated, numerous studies have shown that the proliferative process is stimulated by the growth factors, basic fibroblast growth factor and platelet-derived growth factor.1 2 3 4 5
A remarkable feature of the neointima is that, although lacking endothelium, it rapidly acquires two important features of the endothelialized artery, ie, a nonthrombogenic surface and a relaxed vascular tone. These two phenomena are mediated by endothelium-derived NO, and we have proposed that neointimal SMCs compensate for the loss of endothelium by producing their own NO. In support of this hypothesis, we have shown that an inducible isoform of NO synthase (iNOS) is rapidly induced in SMCs in vivo during the formation of the neointima.6 7 Furthermore, NO is produced in large amounts by the injured artery,6 8 and inhibition of NO production results in increased vascular tone and loss of nonthrombogenicity.7 Furthermore, iNOS may have important regulatory functions in the vessel wall, since NO can inhibit SMC proliferation9 and regulate the expression of several genes, including interleukin-1210 and the vascular cell adhesion molecule-1.11
iNOS was originally identified in cytokine-activated macrophages.12 13 However, studies by us and others have shown that SMCs as well as several other cell types respond to proinflammatory cytokines by transcribing the same iNOS gene as the macrophage.14 15 16 Since iNOS is expressed during neointimal formation but not in the normal arterial wall and since intimal SMCs exhibit a different phenotype and express a set of genes that is not expressed by SMCs of the media,2 5 17 the capacity to express iNOS may be related to the acquisition of the neointimal phenotype.
In the present study, we have examined iNOS expression in neointimal SMCs in vivo and in vitro. Our data indicate that intimal SMCs produce higher levels of NO in response to proinflammatory cytokines than medial SMCs. This was due to an enhanced responsiveness of the iNOS promoter in the intimal cells, which were also relatively resistant to the actions of NO. We propose that NO production via the inducible pathway is a central part of the response-to-injury program of the arterial wall.
Materials and Methods
Recombinant murine IFN-γ was purchased from PharMingen, and recombinant murine TNF-α and IL-1β were from Genzyme. Bacterial LPS (from Escherichia coli serotype O55:B5) and L-NMMA were from Sigma Chemical Co. All reagents, except the LPS itself, contained <0.012 ng/mL endotoxin by the Limulus amebocyte lysate assay.
Cell Culture and SMC Cloning
SMCs were isolated from the medial layer of the thoracic aorta of 6-week-old male Sprague-Dawley rats, and intimal SMCs were derived from the neointimal thickening of the aorta or carotid artery 2 weeks after balloon angioplasty.
Cell cultures were maintained in DMEM supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum (DMEM/10% FCS), 1 mmol/L l-glutamine, 50 U/mL penicillin, and 50 μg/mL streptomycin. Cells from passages 5 to 10 were used for the present studies.
SMC clones were established from normal medial SMC cultures at passage 2 by limiting dilution (at an average of 0.25 cells per well) in 96-well plates in DMEM containing 20% FCS. All wells were inspected every other day for 2 weeks to remove any well suspected to contain more than one clone. Forty clones were selected and passed to 24-well plates and then to 6-well plates. For phenotypic characterization, cloned cells were grown on coverslips, fixed with methanol, and stained with a monoclonal antibody to α-smooth muscle actin (Sigma) followed by FITC-labeled anti-mouse IgG.
The accumulation of NO2−, a stable end product of NO formation, in conditioned medium was measured as an indicator of NO production by SMCs.14 NO2− in the samples was calculated from a standard curve of sodium nitrite. For comparison of NO production by intimal and medial SMC, NO2− values were normalized by the cell number assessed by cell counting in a Coulter counter after trypsinization of parallel cultures.
Male Sprague-Dawley rats (average weight, 400 g; 3 to 4 months old) were used in the experiments, which were approved by the regional ethical committee for animal research. The left carotid artery was denuded as described using a Fogarty 2F balloon catheter (Baxter Healthcare Corp).7 For studying expression and distribution of iNOS, animals were killed under fluanisone/fentanyl citrate anesthesia at the indicated time points after injury. Tissues were snap-frozen in liquid nitrogen and kept at −80°C for immunohistochemistry. Serial cryostat sections (10 μm) were air-dried and fixed for 10 minutes in cold acetone at −20°C. The sections were preincubated with 5% normal swine serum to block nonspecific antibody binding and then incubated overnight at 4°C with polyclonal rabbit antibodies against murine macrophage iNOS (Affiniti BioReagents) diluted 1:500 with PBS. Subsequently, sections were incubated with a biotinylated swine anti-rabbit IgG (Dako) for 30 minutes at room temperature. An avidin-biotin-immunoperoxidase system and 3,3′-diaminobenzidine (Vector Laboratories) were used to detect the antigen-antibody complexes.
Western Blot Analysis
SMCs were lysed with Laemmli sample buffer and denatured by boiling for 5 minutes. The protein concentration was determined using a bicinchonic acid kit (Pierce). For Western blot analysis, 10 μg of protein per lane was separated on 7.5% SDS-polyacrylamide gels and electroblotted to PVTC membranes (Amersham). The membrane was blocked in 5% nonfat dry milk dissolved in TTBS (150 mmol/L NaCl, 10 mmol/L Tris-HCl, and 0.1% Tween 20, pH 7.4) and subsequently incubated for 1 hour at room temperature with a monoclonal antibody against macrophage iNOS (Transduction Laboratory), followed by incubation for 1 hour with horseradish peroxidase–conjugated sheep anti-mouse Ig F(ab′) fragments (Amersham). Immunoreactive bands were visualized using an enhanced chemiluminescence kit (Amersham). Quantification was by densitometric scanning of bands on the developed film.
RNA Isolation and Northern Blot
Total RNA was extracted from cells with an RNA isolation kit (Pharmacia). RNA was size-fractionated in 1% agarose gels containing 0.66 mol/L formaldehyde and transferred to Hybond-N nylon membranes (Amersham). A 4119-bp full-length iNOS cDNA16 was labeled with [α-32P]dCTP using a random-priming DNA labeling kit (Amersham). Filters were prehybridized for 2 to 5 hours at 42°C with a solution containing 5× SSPE (1× SSC contains 150 mmol/L sodium chloride, 10 mmol/L sodium phosphate, and 1 mmol/L EDTA), 5× Denhardt’s solution, 50% deionized formamide, 100 μg/mL salmon sperm DNA, and 0.1% SDS and hybridized overnight at 42°C in the same buffer containing 1×106 cpm/mL denatured probe. After hybridization, the filters were washed twice for 10 minutes at room temperature with 2× SSPE plus 0.1% SDS, for 20 minutes at 65°C with 1× SSPE plus 0.1% SDS, and for 15 minutes at 65°C with 0.1× SSPE plus 1% SDS before autoradiography. To normalize hybridization signals for variations in loading and/or transfer, filters were initially visualized for 18S rRNA by methylene blue staining.
Transfection and CAT Assay
For transfection of SMCs with iNOS promoter constructs, cells (50% confluent) were preincubated in OptiMEM medium (Life Technologies) for 2 hours at 37°C. Cells were transfected with 2 μg of an iNOS promoter–CAT reporter plasmid DNA (piNOS-CAT, Oxford Biomedical Research, Inc) or 2 μg of pCAT 3–basic vector (Promega) by using lipofectin (Life Technologies). pSVβ-galactosidase vector (2 μg, Promega) was cotransfected to all samples as an internal control for the transfection efficiency. Twenty hours after transfection, cells were treated for 20 hours with a combination of 100 U/mL IFN-γ and 10 μg/mL LPS in DMEM with 0.4% FCS. Cell extracts were prepared by three cycles of freeze-thawing and applied for measurement of CAT activity by thin-layer chromatography. β-Galactosidase activity was measured spectrophotometrically at 420 nm by the generation of o-nitrophenol from o-nitrophenyl-β-d-galactopyranoside. All data were normalized as CAT activity units/β-galactosidase activity.
Cells were plated at 2×104 per well in a 24-well plate and allowed to attach in DMEM/10% FCS. After attachment, they were washed with PBS and growth-arrested by replacing the medium with DMEM/0.5% FCS. After 48 hours of growth arrest, cells were released from G0 by the addition of DMEM/10% FCS and simultaneously exposed to IFN-γ or a combination of IFN-γ+TNF-α. At the indicated time points, cells were released from the dish by trypsinization, and the cell number was determined by a Coulter counter.
For evaluation of mitochondrial respiration in SMCs, the MTT reduction assay was performed. SMCs (7×103 per well) were seeded in 96-well plates containing 100 μL of DMEM/10% FCS. MTT (0.1 mg/mL) was added to each well and incubated for 2 hours at 37°C. Thereafter, the culture medium was removed, and the cells were solubilized in 100 μL dimethyl sulfoxide. The extent of reduction of MTT to formazan within cells was quantified at spectrophotometrically at 540 nm and taken as an indicator of cellular respiration. The average absorption in three wells with 7×103 SMCs treated with medium alone was referred to as 100% conversion of MTT. Viability was assessed by trypan blue staining of parallel cultures.
Results are reported as mean±SEM. Student’s t test was used to evaluate the statistical differences between means, and values of P<.05 were considered significant. Nitrite production by SMC clones was analyzed by testing differences between median values using Fisher’s exact test.
Expression of iNOS in the Injured Artery In Vivo
Arterial injury was induced by balloon catheter denudation of the rat common carotid artery, and iNOS expression in the injured artery was followed by immunohistochemistry. Enzyme protein was detectable in medial SMCs as early as 1 day after injury (Fig 1a⇓). When SMCs migrated from media to intima during the first week, iNOS expression was similarly translocated from media to intima (Fig 1b⇓). By 2 weeks after injury, iNOS expression was still intense and confined to the neointimal thickening (Fig 1c⇓). Staining intensity decreased by 4 weeks and was localized to the innermost layer of the neointima, adjacent to the lumen of the artery (Fig 1d⇓). These data imply that the expression of iNOS is closely correlated with the development of the neointima; thus, they suggest that SMCs composing the neointima constitute the major cell population capable of expression of iNOS in the injured artery.
Induction of iNOS in Intimal SMCs
To examine the hypothesis that intimal SMCs are a major source of NO, SMCs were isolated from the neointima of the thoracic aorta and carotid arteries 2 weeks after injury. First, we determined whether intimal SMCs were still able to express iNOS in vitro. Inducible expression of iNOS in intimal SMC cultures from three separate isolates was tested from passages 4 to 7. As shown in Fig 2A⇓, intimal SMCs did not produce NO under baseline conditions. They were, however, able to produce large amounts of NO on stimulation with IL-1β or a combination of IFN-γ and LPS, indicating that intimal SMCs preserve the ability to reexpress iNOS in vitro. Northern analysis using rat SMC iNOS cDNA16 as a probe revealed a 4.1-kb mRNA species (Fig 2B⇓) expressed in the intimal SMC cultures treated with the above-mentioned cytokines. However, no apparent iNOS mRNA or activity was detected in the intimal cultures in the absence of cytokine stimulation (Fig 2A⇓ and 2B⇓). This confirms the fact that intimal SMCs do not express iNOS constitutively in culture.
Comparison of iNOS Expression in Intimal and Medial SMCs
To investigate whether intimal SMCs could be the major cellular source of iNOS, we compared the regulation of iNOS in intimal SMCs with that of medial SMCs derived from uninjured vessels. Intimal SMCs produced markedly higher nitrite levels than did medial SMCs on stimulation with IFN-γ and LPS (Fig 3A⇓). Moreover, LPS alone was able to induce a moderate iNOS expression in the intimal SMCs but had no effect on the medial SMCs (Fig 3B⇓), implying qualitative differences between the two cell types in the signal transduction machinery necessary for iNOS induction. Treatment with IFN-γ alone was, however, not sufficient to induce iNOS expression in either cell type (data not shown). The high iNOS activity in intimal SMCs detected by the nitrite assay was corroborated by the results of Western analysis, which showed a 3-fold larger accumulation of immunoreactive iNOS protein in intimal SMCs than in medial SMCs after stimulation with IFN-γ and LPS (Fig 4⇓, top). Northern analysis demonstrated that intimal SMCs also expressed more iNOS mRNA than did medial SMCs on identical stimulation (Fig 4⇓, bottom). Finally, a single stimulus, ie, IL-1β, was sufficient to induce iNOS mRNA in intimal SMCs, whereas medial SMCs required the synergistic action of IFN-γ and either IL-1β, TNF-α, or LPS (Fig 2B⇑ and data not shown). Taken together, these results reveal that intimal SMCs express significantly more iNOS in response to proinflammatory mediators.
Induction of iNOS in SMC Clones
Several lines of evidence suggest that the arterial media is composed of a heterogeneous population of SMCs, with some SMC cultures derived from the media exhibiting many similarities to intimal SMCs.17 18 We thought that intimal SMCs might be recruited from a subpopulation of SMCs in the media; this would explain the rapid expression of iNOS in the media after injury. To investigate this, we established 42 clones from normal medial SMC cultures using a limiting dilution approach. On the basis of cell morphology and growth pattern, the clones could be divided into three categories, with cobblestone-shaped, spindle-shaped, or senescent features (Table⇓). Both the cobblestone-shaped and the spindle-shaped clones expressed α-smooth muscle actin, indicating that they were of smooth muscle origin. Induction of iNOS in these clones was followed for three passages to determine the stability and reproducibility in the expression of this gene in response to IFN-γ and LPS. The senescent clones, which were highly vacuolated and often multinucleated, grew too slowly to permit further characterization As shown in Fig 5a⇓, the majority of spindle-shaped clones showed low iNOS activity on stimulation, ranging from 0 to 10 nmol/106 cells after 24 hours of exposure to IFN-γ (50 U/mL) and LPS (5 μg/mL). Among cobblestone-shaped clones, there was substantial variation in NO production (Fig 5b⇓), but median values of nitrite were not significantly different between the two clonal phenotypes (10.5 versus 9.5 nmol/106 cells for spindle-shaped versus cobblestone-shaped clones). However, cobblestone-shaped clones appeared to be composed of two types of cells, one characterized by high and the other one by low expression of iNOS (Fig 5b⇓).
The heterogeneity of intimal SMCs with regard to iNOS induction was further supported by Western blot analysis. As shown in Fig 5c⇑, there was substantial variation in iNOS protein between SMC clones treated identically with IFN-γ and LPS. These data suggest that the capacity to express high levels of iNOS on stimulation is not linked to a specific morphological phenotype of SMCs in the media.
Activity of iNOS Promoter/Enhancer in Intimal and Medial SMCs
Given the observations that intimal SMCs demonstrated high iNOS expression and that LPS alone was able to induce iNOS in intimal SMCs, we presumed that intimal SMCs may differ from medial SMCs with regard to transcriptional regulation of the iNOS gene. To test this possibility, intimal and medial SMCs were transfected with a plasmid construct containing 1749 bp of the 5′ flanking region of the murine iNOS gene fused to a CAT reporter gene.19 This region of the iNOS gene contains the basal promoter/enhancer region, with several NF-κB and IFN-γ response elements.19 Transfected cells were stimulated with IFN-γ and LPS, and CAT activity was assessed to evaluate promoter/enhancer activity.
As shown in Fig 6⇓, both intimal and medial SMCs transfected with iNOS/CAT displayed CAT activity after stimulation with IFN-γ and LPS. However, the promoter activity in the intimal SMCs was 3-fold higher than that of the medial SMCs. The promoter activity in the respective cell type was thus compatible with the activity of the endogenous iNOS gene (Fig 4⇑). The difference in promoter activity between the two cell types was unlikely to be due to differences in transfection efficiency, since no significant differences in the transfection efficiency of iNOS/CAT or other reporters were detected.
Effects of Endogenous NO on the Proliferation and Mitochondrial Respiration of SMCs
To evaluate the effect of endogenous NO generated from iNOS on the expressing cell, iNOS was induced by stimulating SMCs with IFN-γ and TNF-α, and cell proliferation was determined in the presence or absence of the NO synthase inhibitor, L-NMMA. IFN-γ+TNF-α significantly reduced the proliferation of both intimal and medial SMCs (Fig 7⇓). The growth inhibition of medial cells could be partially prevented by the NO synthase inhibitor, L-NMMA, indicating that iNOS-derived NO inhibits the growth of these cells. In contrast, L-NMMA did not affect the proliferation of cytokine-treated intimal SMCs (Fig 7⇓). This implies that in the latter cells, NO does not inhibit growth. Instead, the antiproliferative effect of IFN-γ+TNF-α for these cells is likely due to NO-independent mechanisms such as the strong antiproliferative effect of IFN-γ.20 This is supported by the observation that the addition of TNF-α did not further inhibit the proliferation of IFN-γ–treated intimal SMCs (Fig 7⇓). Taken together, these results suggest that intimal SMCs may be more resistant to the action of NO than medial SMCs.
To further confirm this notion, mitochondrial function was determined in intimal and medial SMCs after a 48-hour exposure to IFN-γ and LPS. Mitochondrial respiration was reduced in both cell types but twice as much in medial compared with intimal SMCs (P<.05, Fig 8⇓, top). In both intimal and medial SMCs, the antirespiratory effect could be ascribed to NO, since L-NMMA, an inhibitor of NO synthase, could prevent the inhibitory effect of IFN-γ and LPS (Fig 8⇓, top). The relative resistance of intimal SMCs to NO occurred in spite of the fact that intimal SMCs concomitantly produced significantly more NO than did medial SMCs (Fig 8⇓, bottom). These data thus show that intimal SMCs are equipped not only with a higher capacity to express iNOS on stimulation but also with a relative resistance to the product of this enzyme.
NO is an important mediator in the physiological regulation of vascular tone as well as in pathophysiological processes such as ischemia/reperfusion, atherosclerosis, and acute infections.21 22 23 In the latter case, iNOS gene expression is turned on, and the ensuing high output of NO may account for many events associated with inflammation. A better knowledge of iNOS gene expression in SMCs is therefore crucial to our understanding not only of the physiological importance of NO in response to certain regulatory signals but also of the pathological implications of its prolonged production. The findings reported in the present study suggest that intimal SMCs have unique features of iNOS regulation. First, intimal SMCs are capable of overexpressing iNOS and produce large amounts of NO in response to proinflammatory mediators. Second, this is due to a higher activity of the iNOS promoter/enhancer in intimal compared with medial SMCs, resulting in a lower requirement of external signals for the induction of iNOS transcription. Third, intimal SMCs, compared with medial SMCs, are relatively resistant to the antiproliferative and cytotoxic effects of NO. Thus, intimal SMCs are uniquely suited for producing high levels of NO during the response to injury and disease.
iNOS Expression and SMC Phenotype
The iNOS gene is rapidly turned on and remains expressed in the neointima during several weeks after arterial injury. When intimal SMCs are put into culture, iNOS rapidly disappears. However, it is avidly reexpressed on stimulation with proinflammatory mediators. The fact that iNOS disappears but can be reinduced suggests that its expression in vivo is not a mandatory component of a differentiation program leading to the intimal SMC phenotype. It may rather be due to the combined effect of a reduced threshold for iNOS induction and the presence of inducing stimuli in the neointima of the injured artery. Therefore, whereas the capacity to overexpress iNOS may be linked to SMC differentiation in response to injury, the actual transcription of the iNOS gene is not constitutive but requires stimuli that are present in the neointima and can be induced by the addition of proinflammatory cytokines and IFN-γ to cultured intimal SMCs.
A series of studies show that medial SMCs are heterogeneous with regard to morphology, gene expression, and growth pattern in culture.2 18 24 25 Two major cell types that differ in growth pattern, growth rate, and the expression of contractile proteins have been identified.17 18 These differences are maintained with subculturing, implying that these SMC phenotypes may represent stable differentiation stages. Intimal SMCs isolated from injured arteries are highly similar to one of these subpopulations, which is characterized by a cobblestone-like growth pattern and the lack of myosin heavy chain expression.18 In view of our observation that many intimal but only few medial SMCs express iNOS in the injured artery (References 6 and 76 7 and the present study), we speculated that the capacity to express iNOS may be part of the “intimal phenotype.”
Therefore, SMC clones were established from the arterial media, and iNOS expression and NO production were followed in “intima-like” cobblestone-shaped clones as well as “media-like” spindle-shaped clones. Whereas most of the spindle-shaped SMCs responded rather modestly to iNOS-inducing stimuli, cobblestone-shaped clones were highly heterogeneous. Some cobblestone-shaped SMCs exhibited strong iNOS induction, but there was no significant difference when the median NO production was compared between the two phenotypes. Therefore, the morphology and growth pattern do not, per se, predict the capacity of SMCs to express iNOS, and the vasoregulatory activity in inflammation is not directly linked to the cobblestone-like growth pattern. Instead, a strong iNOS response may be associated with a subpopulation of the cobblestone-shaped SMCs and/or with features of intimal SMCs that are not present in those media-derived SMCs that grow in an intima-like pattern.
Intimal SMCs Are Less Sensitive to NO Than Are Their Medial Counterparts
NO has several negative effects on SMCs. It inhibits their proliferation,9 switches their energy metabolism into the glycolytic pathway by blocking mitochondrial respiration,14 and can, at high concentrations, induce apoptosis.26 These activities may be related, since inhibition of energy metabolism and mitochondrial function have been shown to be related to apoptosis.27 On the molecular level, it is likely that these effects are exerted by reactions between the NO radical and Fe(II)-containing prosthetic groups of several enzymes, including ribonucleotide reductase,28 aconitase, and complexes I and II of the mitochondrial respiratory chain.14 29 These enzymes play critically important roles in the nucleotide and energy metabolism, respectively, of all living cells.
One would therefore expect that intimal SMCs, which have a high proliferative and metabolic rate, should be more sensitive than medial SMCs to NO. It appeared paradoxical that intimal SMCs express more iNOS and produce more NO than do medial SMCs. This stimulated us to compare intimal and medial SMCs with regard to their sensitivity to NO. It was found that intimal SMCs are less sensitive both to the antiproliferative and antimitochondrial effects of iNOS-induced NO, in spite of a larger production of NO. This explains why intimal SMCs survive and grow under conditions of high NO output. Furthermore, it suggests that the major targets of intima-derived NO are not the intimal SMCs. In line with this, we7 have recently found that NO produced in the neointima in vivo inhibits the adhesion of platelets and reduces the arterial tone (which is controlled by medial SMCs). Finally, it implies that important differences in gene regulation may exist between the two kinds of SMCs.
Transcriptional Regulation of iNOS in Intimal SMCs
Studies using immunohistochemistry, in situ hybridization, reverse-transcriptase polymerase chain reaction, and activity analyses have conclusively shown that iNOS is expressed in the intimal SMCs of the injured artery (References 66 to 8 and the present study). This could be due to either the presence of iNOS-inducing stimuli in the neointima or a continuous expression of iNOS as a component of the intimal SMC phenotype. Our current observation that iNOS rapidly disappears in culture supports the former possibility. However, the stimuli required for iNOS induction differed between intimal and medial SMCs, suggesting that an increased capacity to express iNOS may be part of the “intimal phenotype.”
Both qualitative and quantitative differences were observed between intimal and medial SMCs with regard to iNOS induction. When identical stimuli were applied to both cultures, intimal SMCs expressed more iNOS mRNA and protein than did medial SMCs. This was reflected in an 8- to 10-fold higher nitrite production in the intimal cells. The difference was explained by the finding that the iNOS promoter activity, as assessed by a reporter gene construct, was 3-fold higher in the local environment of an intimal compared with a medial SMC. Since there was no evidence for defects in the receptors for IFN-γ, proinflammatory cytokines, or LPS, it is likely that this difference was due to a more efficient signal transduction machinery in the intimal SMCs.
There were, however, also qualitative differences between intimal and medial SMCs in the response to iNOS. In the former, a proinflammatory cytokine (or LPS) alone was sufficient to induce iNOS, whereas synergistic activation by this type of stimulus and IFN-γ was needed in medial SMCs. Since IL-1, TNF, and LPS all use the NF-κB signal transduction pathway, induction of this pathway was needed in both cell types. In contrast, activation of the IFN-γ response pathway was not mandatory in intimal SMCs, although it increased the expression level significantly.
Surprisingly, the iNOS/CAT promoter/reporter construct was only activated by synergistic stimulation with IFN-γ along with IL-1, TNF, or LPS. In contrast, expression of the endogenous iNOS gene could be induced by stimulation with one of the latter alone. This discrepancy could be due to differences in the sensitivity of the detection methods but also to regulatory elements outside the 1749-bp promoter/enhancer sequence used in the reporter construct.
The observation that NF-κB–inducing stimuli are sufficient to induce iNOS expression in intimal SMCs could explain the strong iNOS expression in the neointima, where IFN-γ–producing T cells are sparse. It has recently been shown that TNF-α is expressed after arterial injury and also in atherosclerotic plaques.30 31 Interestingly, NO inhibits NF-κB by inducing IκBα,32 and it is therefore possible that proinflammatory cytokines, NO, and NF-κB are components of a network that controls inflammation in the injured artery by feedback control.
SMCs of the neointima produce large amounts of NO via the inducible pathway, in spite of the fact that autocrine NO production can cause apoptosis of SMCs. The present data clarify that intimal SMCs are less sensitive to the antiproliferative and antimitochondrial effects of NO, which explains how they can survive under conditions of high NO production in the neointima. Furthermore, our data show that compared with medial SMCs, intimal SMCs are less rigorous in their demand for iNOS inducers and express more iNOS in response to a given concentration of stimuli. These differences are maintained in culture and must therefore be linked to a stable intimal SMC phenotype.
In the neointima, the intimal SMC, a cell type with a high capacity to produce NO on stimulation, appears in an environment where several different iNOS-inducing stimuli, such as proinflammatory cytokines and oxidative stress, are present. This explains why iNOS is rapidly induced and large amounts of NO are produced in the injured artery. At this location, NO synthesis is likely to be part of a defense mechanism to protect the tissue from thrombosis and ischemia. Whether iNOS-derived NO actually protects or damages the neointima may depend on the amount of NO produced, ie, on the levels of iNOS-inducing factors in the local milieu.
Selected Abbreviations and Acronyms
|iNOS||=||inducible NO synthase|
|SMC||=||vascular smooth muscle cell|
|TNF-α||=||tumor necrosis factor-α|
This study was supported by the Swedish Medical Research Council (project 6816), the Swedish Heart-Lung Foundation, the Swedish Cancer Society, the Axel and Margaret Johnson Foundation, the Nanna Svartz Fund, the Knut and Alice Wallenberg Foundation, and the King Gustaf V 80th Anniversary Fund. The authors are grateful to Drs Allan Sirsjö and Per Eriksson for advise on transfection experiments. We also thank Ingrid Törnberg for technical assistance.
- Received May 13, 1997.
- Accepted October 8, 1997.
- © 1998 American Heart Association, Inc.
Schwartz SM, deBlois D, O’Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445–465.
Clowes AW, Schwartz SM. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res. 1985;56:139–145.
Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res. 1990;67:651–659.
Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1991;88:3739–3743.
Hansson GK, Geng YJ, Holm J, Hardhammar P, Wennmalm A, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med. 1994;180:733–738.
Yan Z, Yokota T, Zhang W, Hansson GK. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res. 1996;79:38–44.
Joly GA, Schini VB, Vanhoutte PM. Balloon injury induces nitric oxide synthase activity in rat carotid arteries. J Cardiovasc Pharmacol. 1992;20(suppl 12):S151–S154.
Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774–1777.
Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci U S A. 1996;93:9114–9119.
Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 1992;256:225–228.
Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci U S A. 1992;89:6711–6715.
Geng Y, Hansson GK, Holme E. Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res.. 1992;71:1268–1276.
Xie QW, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med. 1993;177:1779–1784.
Hansson GK, Jonasson L, Holm J, Clowes MM, Clowes AW. Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ Res. 1988;63:712–719.
Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 1995;9:1319–1330.
Majesky MW, Reidy MA, Bowen PD, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111(5 pt 1):2149–2158.
Bochaton-Piallat M, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones: implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol. 1996;16:815–820.
Geng YJ, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol. 1996;16:19–27.
Szabo C, Zingarelli B, O’Connor M, Salzman AL. DNA strand breakage, activation of poly(ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A. 1996;93:1753–1758.
Kwon NS, Stuehr DJ, Nathan CF. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med. 1991;174:761–767.
Jovinge S, Hultgårdh-Nilsson A, Regnström J, Nilsson J. Tumor necrosis factor-α activates smooth muscle (SMC) migration in culture and is expressed by medial SMC following balloon injury of rat aorta. Aterioscler Thromb Vasc Biol. 1997;17:490–497.
Peng HB, Libby P, Liao JK. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem. 1995;270:14214–14219.